Pancreatic Cancer Research

ResearcherNingxia Medical UniversityNo recent work listed

Feng Wang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma. First author DOI 10.3233/cbm-181182↗
  2. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway. Last author DOI 10.1016/j.bbrc.2017.10.006↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liya Huang · 2 shared papers, 2017–2018 · strength 0.18
  2. Binwu Ma · 1 shared paper, 2017 · strength 0.10
  3. Yongqiang Hua · 1 shared paper, 2018 · strength 0.08
  4. Zhen Chen · 1 shared paper, 2018 · strength 0.08
  5. Libin Wang · 1 shared paper, 2018 · strength 0.08
  6. Zhiqiang Meng · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.